Related Experiment Video
Updated: Aug 17, 2026
Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Is HBV genotyping of clinical relevance?
V Verschuere1, P S H Yap, J Fevery
1Hepatology, UZ Gasthuisberg, B-3000 Leuven, Belgium.
Insights
Hepatitis B virus (HBV) genotypes vary geographically and may influence disease progression and treatment outcomes. Further research is needed to fully understand the clinical relevance of HBV genotypes.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis B virus (HBV) exhibits diverse genotypes, similar to Hepatitis C virus (HCV).
- Genotyping of HBV relies on nucleotide sequence divergence in surface proteins.
- The clinical and epidemiological significance of HBV genotypes is under investigation.
Purpose of the Study:
- To explore the geographical distribution of HBV genotypes.
- To investigate the potential clinical relevance of HBV genotypes, including their impact on disease progression and treatment response.
Main Methods:
- Genotyping of HBV based on nucleotide sequence divergence.
- Analysis of geographical distribution of different HBV genotypes.
- Review of existing data on clinical outcomes associated with HBV genotypes.
Main Results:
- HBV genotypes show distinct geographical prevalence: A and D in Europe, B and C in Asia, and D in the Middle East.
- Preliminary data suggest genotype A in Europe is linked to higher HBeAg clearance and better outcomes.
- In Asia, genotype B (especially Bj) is associated with increased HBeAg clearance and reduced risk of cirrhosis and HCC.
Conclusions:
- HBV genotypes exhibit significant geographical variations.
- Certain HBV genotypes may be associated with different clinical outcomes and treatment responses.
- Further multi-country studies are required to clarify the impact of HBV genotype alongside other factors on infection course and prognosis.
Abstract:
The hepatitis B virus, as is the case of the hepatitis C virus, can be categorized in several genotypes. The genotyping of HBV is based on the nucleotide sequence divergence encoding the amino acids constituting the HBV surface proteins. Since the genotype of the hepatitis C virus is shown to be related to epidemiology and response to interferon therapy, one wonders whether this also holds for the hepatitis B virus. HBV genotypes clearly are found to be different in various geographical areas of infection. In Europe, genotypes A and D are predominant, whereas in Asian patients genotypes B and C are more frequent, and in the Middle-East the genotype D. Data concerning the clinical relevance are less clear but it seems that in Europe, the genotype A has a higher HBeAg clearance rate and a better outcome. In Asia, genotype B (and especially the genotype Bj) is associated with a higher HBeAg clearance and with less development of cirrhosis and HCC. The impact on spontaneous or therapy induced viral resolution is not yet clearly identified. Further evaluation in different countries is needed to delineate the impact of the genotype relative to other factors such as age at infection, level of serum transaminases and viral load, on the course of infection, complication, outcome of treatment and prognosis.
Related Concept Videos
01:25Hepatitis
01:23Genital Herpes